Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hematologic Malignancies

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Hematologic Malignancies in 2 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawaguchi-Ihara, N1
Zhao, Y1
Nakamura, S1
Suzuki, K1
Zhang, YI1
Tohda, S1
Murohashi, I1
Cerella, C1
Sobolewski, C1
Chateauvieux, S1
Henry, E1
Schnekenburger, M1
Ghelfi, J1
Dicato, M1
Diederich, M1

Other Studies

2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hematologic Malignancies

ArticleYear
Chloroquine Inhibits Self-Renewal of Blast Progenitors Synergistically With Phytochemicals or Nonsteroidal Anti-inflammatory Drugs in Hematological Malignant Cell Lines.
    Anticancer research, 2019, Volume: 39, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Ac

2019
COX-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells.
    Biochemical pharmacology, 2011, Nov-15, Volume: 82, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; DNA Dama

2011